BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc. 1995;70:628-633. [PMID: 7791384 DOI: 10.4065/70.7.628] [Cited by in Crossref: 315] [Cited by in F6Publishing: 246] [Article Influence: 12.1] [Reference Citation Analysis]
Number Citing Articles
1 Barahmani N, Lopez A, Babu D, Hernandez M, Donley SE, Duvic M. Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy. Clinical and Experimental Dermatology 2010;35:409-16. [DOI: 10.1111/j.1365-2230.2009.03523.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
2 Lu J, Zhang P, Hu R, Qi S, Zhao Y, Miao Y, Han Y, Zhou L, Yang Q. Gut microbiota characterization in Chinese patients with alopecia areata. J Dermatol Sci 2021;102:109-15. [PMID: 33893030 DOI: 10.1016/j.jdermsci.2021.04.003] [Reference Citation Analysis]
3 Zimmermann J, Buhl T, Müller M. Alopecia Universalis following Alemtuzumab Treatment in Multiple Sclerosis: A Barely Recognized Manifestation of Secondary Autoimmunity-Report of a Case and Review of the Literature. Front Neurol 2017;8:569. [PMID: 29163335 DOI: 10.3389/fneur.2017.00569] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
4 Andersen LK, Davis MD. The epidemiology of skin and skin-related diseases: a review of population-based studies performed by using the Rochester Epidemiology Project. Mayo Clin Proc 2013;88:1462-7. [PMID: 24290120 DOI: 10.1016/j.mayocp.2013.08.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
5 Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J. Interventions for alopecia areata. Cochrane Database Syst Rev 2008;:CD004413. [PMID: 18425901 DOI: 10.1002/14651858.CD004413.pub2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
6 Lee H, Jung SJ, Patel AB, Thompson JM, Qureshi A, Cho E. Racial characteristics of alopecia areata in the United States. J Am Acad Dermatol 2020;83:1064-70. [PMID: 31279016 DOI: 10.1016/j.jaad.2019.06.1300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tang L, Cao L, Bernardo O, Chen Y, Sundberg JP, Lui H, Chung S, Shapiro J. Topical mechlorethamine restores autoimmune-arrested follicular activity in mice with an alopecia areata-like disease by targeting infiltrated lymphocytes. J Invest Dermatol 2003;120:400-6. [PMID: 12603852 DOI: 10.1046/j.1523-1747.2003.12059.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
8 Kar BR, Handa S, Dogra S, Kumar B. Placebo-controlled oral pulse prednisolone therapy in alopecia areata. J Am Acad Dermatol 2005;52:287-90. [PMID: 15692475 DOI: 10.1016/j.jaad.2004.10.873] [Cited by in Crossref: 71] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
9 Blaumeiser B, van der Goot I, Fimmers R, Hanneken S, Ritzmann S, Seymons K, Betz RC, Ruzicka T, Wienker TF, De Weert J, Lambert J, Kruse R, Nöthen MM. Familial aggregation of alopecia areata. Journal of the American Academy of Dermatology 2006;54:627-32. [DOI: 10.1016/j.jaad.2005.12.007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
10 Rashtak S, Marietta EV, Murray JA. Celiac sprue: a unique autoimmune disorder. Expert Rev Clin Immunol 2009;5:593-604. [PMID: 20477645 DOI: 10.1586/eci.09.30] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
11 Stough D, Stenn K, Haber R, Parsley WM, Vogel JE, Whiting DA, Washenik K. Psychological Effect, Pathophysiology, and Management of Androgenetic Alopecia in Men. Mayo Clinic Proceedings 2005;80:1316-22. [DOI: 10.4065/80.10.1316] [Cited by in Crossref: 70] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
12 Ramot Y, Zlotogorski A. Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient. Skin Appendage Disord 2018;4:122-4. [PMID: 29765973 DOI: 10.1159/000479722] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
13 Harries MJ, Sun J, Paus R, King LE Jr. Management of alopecia areata. BMJ 2010;341:c3671. [PMID: 20656774 DOI: 10.1136/bmj.c3671] [Cited by in Crossref: 55] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
14 Lee S, Lee H, Lee CH, Lee W. Comorbidities in alopecia areata: A systematic review and meta-analysis. Journal of the American Academy of Dermatology 2019;80:466-477.e16. [DOI: 10.1016/j.jaad.2018.07.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 15.0] [Reference Citation Analysis]
15 Xiao F, Zhou F, Liu J, Yan K, Cui Y, Gao M, Liang Y, Sun L, Zhou S, Zhu Y, Zhang X, Yang S. Association of HLA-DQA1 and DQB1 alleles with alolpecia areata in Chinese Hans. Arch Dermatol Res 2005;297:201-9. [DOI: 10.1007/s00403-005-0608-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
16 Mancuso G, Balducci A, Casadio C, Farina P, Staffa M, Valenti L, Milani M. Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: A multicenter, prospective, randomized, controlled, investigator-blinded trial. Int J Dermatol 2003;42:572-5. [DOI: 10.1046/j.1365-4362.2003.01862.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
17 Maia CPA, Fernandes NC. Tratamento da alopecia areata com corticóide tópico: estudo prospectivo randomizado duplo cego em crianças. An Bras Dermatol 2003;78:63-71. [DOI: 10.1590/s0365-05962003000100006] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
18 Lee S, Paik SH, Kim HJ, Ryu HH, Cha S, Jo SJ, Eun HC, Seo JS, Kim JI, Kwon OS. Exomic sequencing of immune-related genes reveals novel candidate variants associated with alopecia universalis. PLoS One 2013;8:e53613. [PMID: 23326468 DOI: 10.1371/journal.pone.0053613] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
19 Qi S, Xu F, Sheng Y, Yang Q. Assessing quality of life in Alopecia areata patients in China. Psychology, Health & Medicine 2014;20:97-102. [DOI: 10.1080/13548506.2014.894641] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
20 Kalkan G, Yigit S, Karakuş N, Ateş O, Bozkurt N, Ozdemir A, Pancar GŞ. Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population. Gene 2013;530:109-12. [PMID: 23954881 DOI: 10.1016/j.gene.2013.08.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
21 Ahn H, Lee SY, Jung WJ, Lee KH. Alopecia treatment using minimally manipulated human umbilical cord-derived mesenchymal stem cells: Three case reports and review of literature. World J Clin Cases 2021;9:3741-51. [PMID: 34046478 DOI: 10.12998/wjcc.v9.i15.3741] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Biran R, Zlotogorski A, Ramot Y. The genetics of alopecia areata: New approaches, new findings, new treatments. Journal of Dermatological Science 2015;78:11-20. [DOI: 10.1016/j.jdermsci.2015.01.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
23 Jagielska D, Redler S, Brockschmidt FF, Herold C, Pasternack SM, Garcia Bartels N, Hanneken S, Eigelshoven S, Refke M, Barth S, Giehl KA, Kruse R, Lutz G, Wolff H, Blaumeiser B, Böhm M, Blume-Peytavi U, Becker T, Nöthen MM, Betz RC. Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance. J Invest Dermatol 2012;132:2192-7. [PMID: 22534877 DOI: 10.1038/jid.2012.129] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
24 Shivanna CB, Shenoy C, Priya RA. Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A Promising Therapy for the Treatment of Alopecia Areata: A Case Report of Six Patients. Int J Trichology 2018;10:103-7. [PMID: 30034188 DOI: 10.4103/ijt.ijt_21_18] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
25 Rahoma S, Sandhu H, Mcdonagh A, Gawkrodger D, Weetman A, Kemp E. Epitopes, avidity and IgG subclasses of tyrosine hydroxylase autoantibodies in vitiligo and alopecia areata patients: Epitope mapping of human tyrosine hydroxylase antibodies. British Journal of Dermatology 2012;167:17-28. [DOI: 10.1111/j.1365-2133.2012.10889.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
26 Sun J, Silva KA, McElwee KJ, King LE Jr, Sundberg JP. The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results. Exp Dermatol 2008;17:793-805. [PMID: 18798913 DOI: 10.1111/j.1600-0625.2008.00773.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
27 Sehgal P, Colombel JF, Narula N. Adverse Events During Anti-TNFα Therapies in IBD (Excluding Infections and Malignancies): When to Stop, Continue, or Switch Therapies. Inflamm Bowel Dis 2016;22:1239-45. [PMID: 26919461 DOI: 10.1097/MIB.0000000000000703] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
28 Broadley D, McElwee KJ. A "hair-raising" history of alopecia areata. Exp Dermatol 2020;29:208-22. [PMID: 31960494 DOI: 10.1111/exd.14073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
29 McElwee KJ, Niiyama S, Freyschmidt-Paul P, Wenzel E, Kissling S, Sundberg JP, Hoffmann R. Dietary soy oil content and soy-derived phytoestrogen genistein increase resistance to alopecia areata onset in C3H/HeJ mice. Exp Dermatol 2003;12:30-6. [PMID: 12631244 DOI: 10.1034/j.1600-0625.2003.120104.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
30 Oh GN, Son SW. Efficacy of korean red ginseng in the treatment of alopecia areata. J Ginseng Res 2012;36:391-5. [PMID: 23717141 DOI: 10.5142/jgr.2012.36.4.391] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
31 Price VH. Therapy of Alopecia Areata: On the Cusp and in the Future. Journal of Investigative Dermatology Symposium Proceedings 2003;8:207-11. [DOI: 10.1046/j.1087-0024.2003.00811.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
32 Rajabi F, Drake LA, Senna MM, Rezaei N. Alopecia areata: a review of disease pathogenesis. Br J Dermatol 2018;179:1033-48. [PMID: 29791718 DOI: 10.1111/bjd.16808] [Cited by in Crossref: 53] [Cited by in F6Publishing: 33] [Article Influence: 17.7] [Reference Citation Analysis]
33 Schäfer N, Blaumeiser B, Becker T, Freudenberg-hua Y, Hanneken S, Eigelshoven S, Schmael C, Lambert J, De Weert J, Kruse R, Nöthen MM, Betz RC. Investigation of the functional variant c.-169T > C of the Fc receptor-like 3 ( FCRL3 ) gene in alopecia areata: FCRL3 in alopecia areata. International Journal of Immunogenetics 2006;33:393-5. [DOI: 10.1111/j.1744-313x.2006.00633.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Cranwell WC, Lai VW, Photiou L, Meah N, Wall D, Rathnayake D, Joseph S, Chitreddy V, Gunatheesan S, Sindhu K, Sharma P, Green J, Eisman S, Yip L, Jones L, Sinclair R. Treatment of alopecia areata: An Australian expert consensus statement. Australas J Dermatol 2019;60:163-70. [DOI: 10.1111/ajd.12941] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
35 Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, Silverberg JI. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis. J Am Acad Dermatol 2020;82:675-82. [PMID: 31437543 DOI: 10.1016/j.jaad.2019.08.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
36 Inui S, Nakajima T, Toda N, Itami S. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases. The Journal of Dermatology 2009;36:323-7. [DOI: 10.1111/j.1346-8138.2009.00647.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
37 Hordinsky MK. Clinical presentations of alopecia areata. Dermatol Ther 2001;14:291-6. [DOI: 10.1046/j.1529-8019.2001.01036.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
38 Subramanya RD, Coda AB, Sinha AA. Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures. Genomics 2010;96:146-53. [PMID: 20546884 DOI: 10.1016/j.ygeno.2010.05.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
39 Chen CC, Chang YT, Liu HN, Chen YJ. Cancer risk in patients with alopecia areata: a nationwide population-based matched cohort study. Cancer Med 2018;7:2153-9. [PMID: 29577672 DOI: 10.1002/cam4.1448] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
40 Kaelin U, Hassan AS, Braathen LR, Yawalkar N. Treatment of alopecia areata partim universalis with efalizumab. J Am Acad Dermatol 2006;55:529-32. [PMID: 16908369 DOI: 10.1016/j.jaad.2006.05.062] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
41 Carlson JA, Malysz J, Schwartz J. Female-patterned alopecia in teenage brothers with unusual histologic features. J Cutan Pathol 2006;33:741-8. [DOI: 10.1111/j.1600-0560.2006.00543.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
42 Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study. J Am Acad Dermatol 2016;74:295-302. [PMID: 26518171 DOI: 10.1016/j.jaad.2015.08.063] [Cited by in Crossref: 65] [Cited by in F6Publishing: 41] [Article Influence: 10.8] [Reference Citation Analysis]
43 Bolduc C, Shapiro J. The treatment of alopecia areata. Dermatol Ther 2001;14:306-16. [DOI: 10.1046/j.1529-8019.2001.01038.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
44 Ucak H, Cicek D, Demir B, Erden I, Ozturk S. Prognostic factors that affect the response to topical treatment in patchy alopecia areata: The response to topical treatment in patchy alopecia areata. Journal of the European Academy of Dermatology and Venereology 2014;28:34-40. [DOI: 10.1111/jdv.12043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
45 Zhang X, Yu M, Yu W, Weinberg J, Shapiro J, McElwee KJ. Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model. J Invest Dermatol 2009;129:1527-38. [PMID: 19020552 DOI: 10.1038/jid.2008.371] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
46 Alkhalifah A. Topical and intralesional therapies for alopecia areata: Therapies for alopecia areata. Dermatologic Therapy 2011;24:355-63. [DOI: 10.1111/j.1529-8019.2011.01419.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
47 Roberts MH, Erdei E. Comparative United States autoimmune disease rates for 2010-2016 by sex, geographic region, and race. Autoimmun Rev 2020;19:102423. [PMID: 31733367 DOI: 10.1016/j.autrev.2019.102423] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
48 Gilhar A, Landau M, Assy B, Ullmann Y, Shalaginov R, Serafimovich S, Kalish RS. Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response. Clin Immunol 2003;106:181-7. [PMID: 12706404 DOI: 10.1016/s1521-6616(02)00042-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
49 Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers 2017;3:17011. [PMID: 28300084 DOI: 10.1038/nrdp.2017.11] [Cited by in Crossref: 140] [Cited by in F6Publishing: 90] [Article Influence: 35.0] [Reference Citation Analysis]
50 Smith A, Trüeb RM, Theiler M, Hauser V, Weibel L. High Relapse Rates Despite Early Intervention with Intravenous Methylprednisolone Pulse Therapy for Severe Childhood Alopecia Areata. Pediatr Dermatol 2015;32:481-7. [PMID: 25872976 DOI: 10.1111/pde.12578] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
51 Cristina C, Mauricio S, Armando L, Celia S, Clara R, Rocío O, Oliverio W, Jorge O. Tumor necrosis factor alpha promoter-308G/A polymorphism in Mexican patients with patchy alopecia areata: TNFα-308G/A polymorphism in Mexican patients with patchy AA. International Journal of Dermatology 2012;51:571-5. [DOI: 10.1111/j.1365-4632.2011.05291.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
52 Pan Y, Rao NA. Alopecia areata during etanercept therapy. Ocul Immunol Inflamm 2009;17:127-9. [PMID: 19412875 DOI: 10.1080/09273940802596559] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
53 Duvic M, Norris D, Christiano A, Hordinsky M, Price V. Alopecia Areata Registry: An Overview. Journal of Investigative Dermatology Symposium Proceedings 2003;8:219-21. [DOI: 10.1046/j.1087-0024.2003.00814.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
54 Thompson JM, Park MK, Qureshi AA, Cho E. Race and Alopecia Areata amongst US Women. Journal of Investigative Dermatology Symposium Proceedings 2018;19:S47-50. [DOI: 10.1016/j.jisp.2017.10.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
55 Gohary YM, Abdel Fattah DS. Detection of Tumor Necrosis Factor-alpha in Nonlesional Tissues of Alopecia Areata Patients: A Prove for a Systemic Disease. Int J Trichology 2017;9:154-9. [PMID: 29118519 DOI: 10.4103/ijt.ijt_47_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
56 Dai YX, Tai YH, Chen CC, Chang YT, Chen TJ, Chen MH. Bidirectional association between alopecia areata and major depressive disorder among probands and unaffected siblings: A nationwide population-based study. J Am Acad Dermatol 2020;82:1131-7. [PMID: 32007291 DOI: 10.1016/j.jaad.2019.11.064] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 18.0] [Reference Citation Analysis]
57 Gregoriou S, Papafragkaki D, Kontochristopoulos G, Rallis E, Kalogeromitros D, Rigopoulos D. Cytokines and other mediators in alopecia areata. Mediators Inflamm 2010;2010:928030. [PMID: 20300578 DOI: 10.1155/2010/928030] [Cited by in Crossref: 55] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
58 Ghoreishi M, Martinka M, Dutz JP. Type 1 interferon signature in the scalp lesions of alopecia areata. Br J Dermatol 2010;163:57-62. [PMID: 20346028 DOI: 10.1111/j.1365-2133.2010.09775.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
59 Kennedy Crispin M, Ko JM, Craiglow BG, Li S, Shankar G, Urban JR, Chen JC, Cerise JE, Jabbari A, Winge MC, Marinkovich MP, Christiano AM, Oro AE, King BA. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI Insight 2016;1:e89776. [PMID: 27699252 DOI: 10.1172/jci.insight.89776] [Cited by in Crossref: 121] [Cited by in F6Publishing: 106] [Article Influence: 24.2] [Reference Citation Analysis]
60 Andersen LK, Davis MD. Sex differences in the incidence of skin and skin-related diseases in Olmsted County, Minnesota, United States, and a comparison with other rates published worldwide. Int J Dermatol 2016;55:939-55. [PMID: 27009931 DOI: 10.1111/ijd.13285] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 4.4] [Reference Citation Analysis]
61 Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J. Alopecia areata. Journal of the American Academy of Dermatology 2018;78:1-12. [DOI: 10.1016/j.jaad.2017.04.1141] [Cited by in Crossref: 108] [Cited by in F6Publishing: 69] [Article Influence: 36.0] [Reference Citation Analysis]
62 Ucak H, Soylu E, Ozturk S, Demir B, Cicek D, Erden I, Akyigit A. Audiological abnormalities in patients with alopecia areata. J Eur Acad Dermatol Venereol 2014;28:1045-8. [DOI: 10.1111/jdv.12259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
63 Kim SK, Park HJ, Chung JH, Kim JW, Seok H, Lew BL, Sim WY. Association between interleukin 18 polymorphisms and alopecia areata in Koreans. J Interferon Cytokine Res 2014;34:349-53. [PMID: 24446726 DOI: 10.1089/jir.2013.0055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
64 Sharma VK, Muralidhar S, Kumar B. Reappraisal of Ikeda's Classification of Alopecia Areata: Analysis of 356 Cases from Chandigarh, India. The Journal of Dermatology 1998;25:108-11. [DOI: 10.1111/j.1346-8138.1998.tb02359.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
65 Mcelwee KJ, Boggess D, Sundberg JP, King Jr LE. Experimental Induction of Alopecia Areata-Like Hair Loss in C3H/HeJ Mice Using Full-Thickness Skin Grafts. Journal of Investigative Dermatology 1998;111:797-803. [DOI: 10.1046/j.1523-1747.1998.00380.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 4.7] [Reference Citation Analysis]
66 Trüeb RM, Dias MFRG. Alopecia Areata: a Comprehensive Review of Pathogenesis and Management. Clin Rev Allergy Immunol 2018;54:68-87. [PMID: 28717940 DOI: 10.1007/s12016-017-8620-9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 15.0] [Reference Citation Analysis]
67 Gilhar A, Landau M, Assy B, Shalaginov R, Serafimovich S, Kalish RS. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice. J Invest Dermatol 2001;117:1357-62. [PMID: 11886495 DOI: 10.1046/j.0022-202x.2001.01583.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 76] [Article Influence: 5.4] [Reference Citation Analysis]
68 Olsen EA, Roberts J, Sperling L, Tosti A, Shapiro J, McMichael A, Bergfeld W, Callender V, Mirmirani P, Washenik K, Whiting D, Cotsarelis G, Hordinsky M. Objective outcome measures: Collecting meaningful data on alopecia areata. J Am Acad Dermatol 2018;79:470-478.e3. [PMID: 29128463 DOI: 10.1016/j.jaad.2017.10.048] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
69 Hosking AM, Juhasz M, Atanaskova Mesinkovska N. Complementary and Alternative Treatments for Alopecia: A Comprehensive Review. Skin Appendage Disord 2019;5:72-89. [PMID: 30815439 DOI: 10.1159/000492035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
70 Whiting DA. The histopathology of alopecia areata in vertical and horizontal sections. Dermatol Ther 2001;14:297-305. [DOI: 10.1046/j.1529-8019.2001.01037.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
71 Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, Kim H, Singh P, Lee A, Chen WV. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 2010;466:113-117. [PMID: 20596022 DOI: 10.1038/nature09114] [Cited by in Crossref: 429] [Cited by in F6Publishing: 333] [Article Influence: 39.0] [Reference Citation Analysis]
72 Tobin DJ, Alhaidari Z, Olivry T. Equine alopecia areata autoantibodies target multiple hair follicle antigens and may alter hair growth. Experimental Dermatology 1998;7:289-97. [DOI: 10.1111/j.1600-0625.1998.tb00299.x-i1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
73 El Khoury J, Abd-el-baki J, Succariah F, Abbas O, Kibbi AG, Kurban M. Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience. International Journal of Dermatology 2013;52:1551-6. [DOI: 10.1111/ijd.12226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
74 Wikramanayake TC, Rodriguez R, Choudhary S, Mauro LM, Nouri K, Schachner LA, Jimenez JJ. Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata. Lasers Med Sci 2012;27:431-6. [PMID: 21739260 DOI: 10.1007/s10103-011-0953-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 36] [Article Influence: 5.5] [Reference Citation Analysis]
75 Benigno M, Anastassopoulos KP, Mostaghimi A, Udall M, Daniel SR, Cappelleri JC, Chander P, Wahl PM, Lapthorn J, Kauffman L, Chen L, Peeva E. A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States. Clin Cosmet Investig Dermatol 2020;13:259-66. [PMID: 32280257 DOI: 10.2147/CCID.S245649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
76 Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR, Spritz RA. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo: Autoimmune epidemiology of familial vitiligo. Pigment Cell Research 2005;18:300-5. [DOI: 10.1111/j.1600-0749.2005.00242.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 93] [Article Influence: 7.2] [Reference Citation Analysis]
77 Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 2012;11:754-65. [PMID: 22387972 DOI: 10.1016/j.autrev.2012.02.001] [Cited by in Crossref: 213] [Cited by in F6Publishing: 167] [Article Influence: 23.7] [Reference Citation Analysis]
78 Cruz AA, Akaishi PM, Vargas MA, de Paula SA. Association between thyroid autoimmune dysfunction and non-thyroid autoimmune diseases. Ophthalmic Plast Reconstr Surg 2007;23:104-8. [PMID: 17413622 DOI: 10.1097/IOP.0b013e318030b06b] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
79 Redler S, Brockschmidt FF, Forstbauer L, Giehl KA, Herold C, Eigelshoven S, Hanneken S, De Weert J, Lutz G, Wolff H, Kruse R, Blaumeiser B, Böhm M, Becker T, Nöthen MM, Betz RC. The TRAF1/C5 locus confers risk for familial and severe alopecia areata. Br J Dermatol 2010;162:866-9. [PMID: 20030635 DOI: 10.1111/j.1365-2133.2009.09598.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
80 Wambier CG, King BA. Rethinking the classification of alopecia areata. Journal of the American Academy of Dermatology 2019;80:e45. [DOI: 10.1016/j.jaad.2018.08.059] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
81 Wang EHC, Destefano GM, Patel AV, Drill E, Harel S, Cela C, Tavazoie M, Christiano AM. Identification of differentially expressed miRNAs in alopecia areata that target immune-regulatory pathways. Genes Immun 2017;18:100-4. [DOI: 10.1038/gene.2017.4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
82 Hunt N, Mchale S. REPORTED EXPERIENCES OF PERSONS WITH ALOPECIA AREATA. Journal of Loss and Trauma 2004;10:33-50. [DOI: 10.1080/15325020490890633] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
83 Freyschmidt-paul P, Hoffmann R, Mcelwee KJ. Alopecia Areata. In: Blume-peytavi U, Tosti A, Trüeb RM, editors. Hair Growth and Disorders. Berlin: Springer Berlin Heidelberg; 2008. pp. 311-32. [DOI: 10.1007/978-3-540-46911-7_15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
84 Kassim J, Shipman A, Szczecinska W, Siah T, Lam M, Chalmers J, Macbeth A. How effective is intralesional injection of triamcinolone acetonide compared with topical treatments in inducing and maintaining hair growth in patients with alopecia areata? A Critically Appraised Topic. Br J Dermatol 2014;170:766-71. [DOI: 10.1111/bjd.12863] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
85 Macbeth A, Tomlinson J, Messenger A, Moore-millar K, Michaelides C, Shipman A, Kassim J, Brockley J, Szczecinska W, Farrant P, Robinson R, Rodgers J, Chambers J, Upadhyaya S, Harries M. Establishing and prioritizing research questions for the treatment of alopecia areata: the Alopecia Areata Priority Setting Partnership. Br J Dermatol 2017;176:1316-20. [DOI: 10.1111/bjd.15099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
86 Kalkan G, Karakus N, Baş Y, Takçı Z, Özuğuz P, Ateş Ö, Yigit S. The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population. Gene 2013;527:565-9. [DOI: 10.1016/j.gene.2013.05.086] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
87 Dai YX, Tai YH, Chen CC, Chang YT, Chen TJ, Chen MH. Bidirectional association between alopecia areata and sleep disorders: a population-based cohort study in Taiwan. Sleep Med 2020;75:112-6. [PMID: 32858349 DOI: 10.1016/j.sleep.2020.06.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
88 Bertolini M, Gilhar A, Paus R. Alopecia areata as a model for T cell-dependent autoimmune diseases: Meeting Report. Exp Dermatol 2012;21:477-9. [DOI: 10.1111/j.1600-0625.2011.01427.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
89 Fischer J, Degenhardt F, Hofmann A, Redler S, Basmanav FB, Heilmann-Heimbach S, Hanneken S, Giehl KA, Wolff H, Moebus S, Kruse R, Lutz G, Blaumeiser B, Böhm M, Garcia Bartels N, Blume-Peytavi U, Petukhova L, Christiano AM, Nöthen MM, Betz RC. Genomewide analysis of copy number variants in alopecia areata in a Central European cohort reveals association with MCHR2. Exp Dermatol 2017;26:536-41. [PMID: 27306922 DOI: 10.1111/exd.13123] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
90 Phan K, Sebaratnam DF. JAK inhibitors for alopecia areata: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2019;33:850-856. [PMID: 30762909 DOI: 10.1111/jdv.15489] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 19.5] [Reference Citation Analysis]
91 Jabbari A, Petukhova L, Cabral RM, Clynes R, Christiano AM. Genetic basis of alopecia areata: a roadmap for translational research. Dermatol Clin 2013;31:109-17. [PMID: 23159180 DOI: 10.1016/j.det.2012.08.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
92 Zöller M, Mcelwee KJ, Vitacolonna M, Hoffmann R. Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients. Journal of Autoimmunity 2004;23:241-56. [DOI: 10.1016/j.jaut.2004.08.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
93 Pelivani N, Hassan AS, Braathen LR, Hunger RE, Yawalkar N. Alopecia areata universalis elicited during treatment with adalimumab. Dermatology 2008;216:320-3. [PMID: 18230980 DOI: 10.1159/000113945] [Cited by in Crossref: 47] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
94 Yousefi M, Namazi MR, Rahimi H, Younespour S, Ehsani AH, Shakoei S. Evaluation of Serum Homocysteine, High-Sensitivity CRP, and RBC Folate in Patients with Alopecia Areata. Indian J Dermatol 2014;59:630. [PMID: 25484412 DOI: 10.4103/0019-5154.143567] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
95 Esbensen AJ. Health conditions associated with aging and end of life of adults with Down syndrome. Int Rev Res Ment Retard 2010;39:107-26. [PMID: 21197120 DOI: 10.1016/S0074-7750(10)39004-5] [Cited by in Crossref: 89] [Cited by in F6Publishing: 34] [Article Influence: 8.1] [Reference Citation Analysis]
96 Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 2007;117:2019-27. [PMID: 17671634 DOI: 10.1172/JCI31942] [Cited by in Crossref: 176] [Cited by in F6Publishing: 46] [Article Influence: 12.6] [Reference Citation Analysis]
97 Sundberg JP, Boggess D, Silva KA, McElwee KJ, King LE, Li R, Churchill G, Cox GA. Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J Invest Dermatol 2003;120:771-5. [PMID: 12713579 DOI: 10.1046/j.1523-1747.2003.12135.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
98 Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003;16:208-14. [PMID: 12753387 DOI: 10.1034/j.1600-0749.2003.00032.x] [Cited by in Crossref: 402] [Cited by in F6Publishing: 286] [Article Influence: 23.6] [Reference Citation Analysis]
99 Fagan N, Meah N, York K, Bokhari L, Fletcher G, Chen G, Tobin DJ, Messenger A, Irvine AD, Sinclair R, Wall D. Shedding light on therapeutics in alopecia and their relevance to COVID-19. Clin Dermatol 2021;39:76-83. [PMID: 33972056 DOI: 10.1016/j.clindermatol.2020.12.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Burns LJ, Mesinkovska N, Kranz D, Ellison A, Senna MM. Cumulative Life Course Impairment of Alopecia Areata. Int J Trichology 2020;12:197-204. [PMID: 33531741 DOI: 10.4103/ijt.ijt_99_20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
101 Hordinsky MK. Treatment of alopecia areata: “What is new on the horizon?”: Treatment of alopecia areata. Dermatologic Therapy 2011;24:364-8. [DOI: 10.1111/j.1529-8019.2011.01421.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
102 Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata. Int J Dermatol. 2007;46:121-131. [PMID: 17269961 DOI: 10.1111/j.1365-4632.2007.03193.x] [Cited by in Crossref: 131] [Cited by in F6Publishing: 80] [Article Influence: 9.4] [Reference Citation Analysis]
103 Sundberg JP, Silva KA, Zhang W, Sundberg BA, Edwards K, King LE, Davis RL, Black S. Recombinant human hepatitis B vaccine initiating alopecia areata: testing the hypothesis using the C3H/HeJ mouse model. Vet Dermatol 2009;20:99-104. [PMID: 19175564 DOI: 10.1111/j.1365-3164.2008.00692.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
104 Liu LY, Craiglow BG, Dai F, King BA. Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients. J Am Acad Dermatol 2017;76:22-8. [PMID: 27816293 DOI: 10.1016/j.jaad.2016.09.007] [Cited by in Crossref: 138] [Cited by in F6Publishing: 107] [Article Influence: 27.6] [Reference Citation Analysis]
105 Kridin K, Renert-Yuval Y, Guttman-Yassky E, Cohen AD. Alopecia Areata Is Associated with Atopic Diathesis: Results from a Population-Based Study of 51,561 Patients. J Allergy Clin Immunol Pract 2020;8:1323-1328.e1. [PMID: 32036002 DOI: 10.1016/j.jaip.2020.01.052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
106 Alkhalifah A. Alopecia Areata Update. Dermatologic Clinics 2013;31:93-108. [DOI: 10.1016/j.det.2012.08.010] [Cited by in Crossref: 46] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
107 Mirzoyev SA, Schrum AG, Davis MDP, Torgerson RR. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009. J Invest Dermatol. 2014;134:1141-1142. [PMID: 24202232 DOI: 10.1038/jid.2013.464] [Cited by in Crossref: 106] [Cited by in F6Publishing: 71] [Article Influence: 13.3] [Reference Citation Analysis]
108 Wohlmuth-Wieser I, Osei JS, Norris D, Price V, Hordinsky MK, Christiano A, Duvic M. Childhood alopecia areata-Data from the National Alopecia Areata Registry. Pediatr Dermatol 2018;35:164-9. [PMID: 29334143 DOI: 10.1111/pde.13387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
109 Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol. 2000;42:549-566. [PMID: 10727299 DOI: 10.1067/mjd.2000.103909] [Cited by in Crossref: 188] [Cited by in F6Publishing: 92] [Article Influence: 9.0] [Reference Citation Analysis]
110 Monselise A, Bar-On R, Chan L, Leibushor N, McElwee K, Shapiro J. Examining the relationship between alopecia areata, androgenetic alopecia, and emotional intelligence. J Cutan Med Surg 2013;17:46-51. [PMID: 23364150 DOI: 10.2310/7750.2012.12003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
111 Tang L, Lui H, Sundberg JP, Bissonnette R, McLean DI, Shapiro J. Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata. J Am Acad Dermatol 2003;49:1013-9. [PMID: 14639378 DOI: 10.1016/s0190-9622(03)02141-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
112 Leung MC, Sutton CW, Fenton DA, Tobin DJ. Trichohyalin is a Potential Major Autoantigen in Human Alopecia Areata. J Proteome Res 2010;9:5153-63. [DOI: 10.1021/pr100422u] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
113 Lenane P, Pope E, Krafchik B. Congenital alopecia areata. Journal of the American Academy of Dermatology 2005;52:S8-S11. [DOI: 10.1016/j.jaad.2004.06.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
114 Royer M, Bodemer C, Vabres P, Pajot C, Barbarot S, Paul C, Mazereeuw J. Efficacy and tolerability of methotrexate in severe childhood alopecia areata: Efficacy and tolerability of methotrexate in severe childhood AA. British Journal of Dermatology 2011;165:407-10. [DOI: 10.1111/j.1365-2133.2011.10383.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
115 Peloquin L, Castelo-soccio L. Alopecia Areata: An Update on Treatment Options for Children. Pediatr Drugs 2017;19:411-22. [DOI: 10.1007/s40272-017-0239-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
116 Zhao M, Liang G, Wu X, Wang S, Zhang P, Su Y, Yin H, Tan Y, Zhang J, Lu Q. Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata. Br J Dermatol 2012;166:226-73. [PMID: 21936853 DOI: 10.1111/j.1365-2133.2011.10646.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
117 Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33:197-207. [PMID: 19819109 DOI: 10.1016/j.jaut.2009.09.008] [Cited by in Crossref: 389] [Cited by in F6Publishing: 313] [Article Influence: 32.4] [Reference Citation Analysis]
118 Hamilton CE, Craiglow BG. JAK Inhibitors for the Treatment of Pediatric Alopecia Areata. J Investig Dermatol Symp Proc. 2020;20:S31-S36. [PMID: 33099381 DOI: 10.1016/j.jisp.2020.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
119 Wang ECE, Christiano AM. The Changing Landscape of Alopecia Areata: The Translational Landscape. Adv Ther 2017;34:1586-93. [PMID: 28646392 DOI: 10.1007/s12325-017-0540-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
120 Janković S, Perić J, Maksimović N, Ćirković A, Marinković J, Janković J, Reljić V, Medenica L. Quality of life in patients with alopecia areata: a hospital-based cross-sectional study. J Eur Acad Dermatol Venereol 2016;30:840-6. [DOI: 10.1111/jdv.13520] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
121 Wang EHC, Yu M, Breitkopf T, Akhoundsadegh N, Wang X, Shi FT, Leung G, Dutz JP, Shapiro J, McElwee KJ. Identification of Autoantigen Epitopes in Alopecia Areata. J Invest Dermatol 2016;136:1617-26. [PMID: 27094591 DOI: 10.1016/j.jid.2016.04.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
122 Barahmani N, Schabath MB, Duvic M. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol. 2009;61:581-591. [PMID: 19608295 DOI: 10.1016/j.jaad.2009.04.031] [Cited by in Crossref: 93] [Cited by in F6Publishing: 69] [Article Influence: 7.8] [Reference Citation Analysis]
123 Barankin B, Taher M, Wasel N. Successful Hair Transplant of Eyebrow Alopecia Areata. J Cutan Med Surg 2005;9:162-4. [DOI: 10.1177/120347540500900402] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
124 Welsh O. Phototherapy for alopecia areata. Clin Dermatol 2016;34:628-32. [PMID: 27638443 DOI: 10.1016/j.clindermatol.2016.05.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
125 Mcelwee KJ, Yu M, Park S, Ross EK, Finner A, Shapiro J. What Can We Learn from Animal Models of Alopecia areata? Dermatology 2005;211:47-53. [DOI: 10.1159/000085580] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
126 Lyakhovitsky A, Shemer A, Amichai B. Increased prevalence of thyroid disorders in patients with new onset alopecia areata. Australas J Dermatol 2015;56:103-6. [PMID: 25303421 DOI: 10.1111/ajd.12178] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
127 Yoshimasu T, Furukawa F. Modified immunotherapy for alopecia areata. Autoimmunity Reviews 2016;15:664-7. [DOI: 10.1016/j.autrev.2016.02.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
128 Forstbauer LM, Brockschmidt FF, Moskvina V, Herold C, Redler S, Herzog A, Hillmer AM, Meesters C, Heilmann S, Albert F, Alblas M, Hanneken S, Eigelshoven S, Giehl KA, Jagielska D, Blume-Peytavi U, Garcia Bartels N, Kuhn J, Hennies HC, Goebeler M, Jung A, Peitsch WK, Kortüm AK, Moll I, Kruse R, Lutz G, Wolff H, Blaumeiser B, Böhm M, Kirov G, Becker T, Nöthen MM, Betz RC. Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata. Eur J Hum Genet 2012;20:326-32. [PMID: 22027810 DOI: 10.1038/ejhg.2011.185] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
129 Tang L, Cao L, Sundberg JP, Lui H, Shapiro J. Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin. Exp Dermatol 2004;13:5-10. [DOI: 10.1111/j.0906-6705.2004.00098.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
130 Vélez-Muñiz RDC, Peralta-Pedrero ML, Jurado-Santa Cruz F, Morales-Sánchez MA. Psychological Profile and Quality of Life of Patients with Alopecia Areata. Skin Appendage Disord 2019;5:293-8. [PMID: 31559253 DOI: 10.1159/000497166] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
131 Guttikonda AS, Aruna C, Ramamurthy DV, Sridevi K, Alagappan SK. Evaluation of Clinical Significance of Dermoscopy in Alopecia Areata. Indian J Dermatol 2016;61:628-33. [PMID: 27904180 DOI: 10.4103/0019-5154.193668] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
132 Kasumagic-Halilovic E, Prohic A, Cavaljuga S. Tumor necrosis factor-alpha in patients with alopecia areata. Indian J Dermatol 2011;56:494-6. [PMID: 22121261 DOI: 10.4103/0019-5154.87124] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
133 Lee S, Lee YB, Kim BJ, Bae S, Lee WS. All-Cause and Cause-Specific Mortality Risks Associated With Alopecia Areata: A Korean Nationwide Population-Based Study. JAMA Dermatol 2019;155:922-8. [PMID: 31141109 DOI: 10.1001/jamadermatol.2019.0629] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
134 Price VH, Hordinsky MK, Olsen EA, Roberts JL, Siegfried EC, Rafal ES, Korman NJ, Altrabulsi B, Leung HM, Garovoy MR, Caro I, Whiting DA. Subcutaneous efalizumab is not effective in the treatment of alopecia areata. J Am Acad Dermatol 2008;58:395-402. [PMID: 18280336 DOI: 10.1016/j.jaad.2007.10.645] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
135 Lazzarini R, Capareli GC, Buense R, Lellis RF. Alopecia universalis during treatment with leflunomide and adalimumab - case report. An Bras Dermatol 2014;89:320-2. [PMID: 24770511 DOI: 10.1590/abd1806-4841.20142944] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
136 Jahn-Bassler K, Bauer WM, Karlhofer F, Vossen MG, Stingl G. Sequential high- and low-dose systemic corticosteroid therapy for severe childhood alopecia areata. J Dtsch Dermatol Ges 2017;15:42-7. [PMID: 28140540 DOI: 10.1111/ddg.12875] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
137 Kasumagić-Halilovic E, Cavaljuga S, Ovcina-Kurtovic N, Zecevic L. Serum Levels of Interleukin-2 in Patients with Alopecia Areata: Relationship with Clinical Type and Duration of the Disease. Skin Appendage Disord 2018;4:286-90. [PMID: 30410898 DOI: 10.1159/000486462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
138 Chu SY, Chen YJ, Tseng WC, Lin MW, Chen TJ, Hwang CY, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN. Psychiatric comorbidities in patients with alopecia areata in Taiwan: a case-control study. Br J Dermatol 2012;166:525-31. [PMID: 22049923 DOI: 10.1111/j.1365-2133.2011.10714.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
139 Rivitti EA. Alopecia areata: revisão e atualização. An Bras Dermatol 2005;80:57-68. [DOI: 10.1590/s0365-05962005000100009] [Cited by in Crossref: 16] [Article Influence: 1.0] [Reference Citation Analysis]
140 Petukhova L, Christiano AM. The genetic architecture of alopecia areata. J Investig Dermatol Symp Proc 2013;16:S16-22. [PMID: 24326542 DOI: 10.1038/jidsymp.2013.5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
141 Jabbari A, Sansaricq F, Cerise J, Chen JC, Bitterman A, Ulerio G, Borbon J, Clynes R, Christiano AM, Mackay-Wiggan J. An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis. J Invest Dermatol 2018;138:1539-45. [PMID: 29452121 DOI: 10.1016/j.jid.2018.01.032] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 21.0] [Reference Citation Analysis]
142 Duncan FJ, Silva KA, Johnson CJ, King BL, Szatkiewicz JP, Kamdar SP, Ong DE, Napoli JL, Wang J, King LE Jr, Whiting DA, McElwee KJ, Sundberg JP, Everts HB. Endogenous retinoids in the pathogenesis of alopecia areata. J Invest Dermatol 2013;133:334-43. [PMID: 23014334 DOI: 10.1038/jid.2012.344] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
143 Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol 2006;20:1055-60. [PMID: 16987257 DOI: 10.1111/j.1468-3083.2006.01676.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 88] [Article Influence: 8.3] [Reference Citation Analysis]
144 Kalkan G, Ateş O, Karakuş N, Sezer S. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of alopecia areata. Arch Dermatol Res 2013;305:909-15. [PMID: 23591741 DOI: 10.1007/s00403-013-1354-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
145 Islam N, Leung PS, Huntley AC, Eric Gershwin M. The autoimmune basis of alopecia areata: A comprehensive review. Autoimmunity Reviews 2015;14:81-9. [DOI: 10.1016/j.autrev.2014.10.014] [Cited by in Crossref: 82] [Cited by in F6Publishing: 65] [Article Influence: 13.7] [Reference Citation Analysis]
146 Kemp E, Sandhu H, Weetman A, Mcdonagh A. Demonstration of autoantibodies against tyrosine hydroxylase in patients with alopecia areata: Autoantibodies in alopecia areata. British Journal of Dermatology 2011;165:1236-43. [DOI: 10.1111/j.1365-2133.2011.10597.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
147 John KK, Brockschmidt FF, Redler S, Herold C, Hanneken S, Eigelshoven S, Giehl KA, De Weert J, Lutz G, Kruse R, Wolff H, Blaumeiser B, Böhm M, Becker T, Nöthen MM, Betz RC. Genetic variants in CTLA4 are strongly associated with alopecia areata. J Invest Dermatol 2011;131:1169-72. [PMID: 21346773 DOI: 10.1038/jid.2010.427] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
148 Kalish RS, Gilhar A. The immunology of alopecia areata and potential application to novel therapies. Dermatol Ther 2001;14:322-8. [DOI: 10.1046/j.1529-8019.2001.01035.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
149 García Hernández MJ, Camacho F. Epidemiología clínica de la alopecia areata. Actas Dermo-Sifiliográficas 2002;93:223-8. [DOI: 10.1016/s0001-7310(02)76562-9] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
150 Sundberg JP, Silva KA, Li R, Cox GA, King LE. Adult-onset Alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. J Invest Dermatol 2004;123:294-7. [PMID: 15245428 DOI: 10.1111/j.0022-202X.2004.23222.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
151 Chiang A, Ortenzio F, Juhasz MLW, Yu V, Mesinkovska NA. Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature. JAAD Case Rep 2018;4:733-6. [PMID: 30167448 DOI: 10.1016/j.jdcr.2018.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
152 Bolduc C, Bissonnette R. Safety and efficacy of adalimumab for the treatment of severe alopecia areata: case series of three patients. J Cutan Med Surg 2012;16:257-60. [PMID: 22784518 DOI: 10.1177/120347541201600407] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
153 Mcmichael AJ. The genetic epidemiology and autoimmune pathogenesis of alopecia areata. J Eur Acad Dermatol Venerol 1997;9:36-43. [DOI: 10.1111/j.1468-3083.1997.tb00225.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
154 Giangreco A, Hoste E, Takai Y, Rosewell I, Watt FM. Epidermal Cadm1 Expression Promotes Autoimmune Alopecia via Enhanced T Cell Adhesion and Cytotoxicity. J I 2012;188:1514-22. [DOI: 10.4049/jimmunol.1003342] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
155 Wang E, McElwee KJ. Etiopathogenesis of alopecia areata: Why do our patients get it? Dermatol Ther 2011;24:337-47. [PMID: 21689243 DOI: 10.1111/j.1529-8019.2011.01416.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
156 Feizy V, Mortazavi H, Barikbin B, Yousefi M, Ranjbar A, Farshchian M. Serum selenium level in Iranian patients with alopecia areata. J Eur Acad Dermatol Venereol 2008;22:1259-60. [PMID: 18452532 DOI: 10.1111/j.1468-3083.2008.02612.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
157 Dy LC, Whiting DA. Histopathology of alopecia areata, acute and chronic: Why is it important to the clinician?: Alopecia areata, follicular counts, horizontal. Dermatologic Therapy 2011;24:369-74. [DOI: 10.1111/j.1529-8019.2011.01414.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
158 Dai YX, Yeh FY, Shen YJ, Tai YH, Chou YJ, Chang YT, Chen TJ, Li CP, Wu CY. Cigarette Smoking, Alcohol Consumption, and Risk of Alopecia Areata: A Population-Based Cohort Study in Taiwan. Am J Clin Dermatol 2020;21:901-11. [PMID: 32761499 DOI: 10.1007/s40257-020-00547-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
159 Barankin B, Taher M, Wasel N. Successful hair transplant of eyebrow alopecia areata. J Cutan Med Surg 2005;9:162-4. [PMID: 16502201 DOI: 10.1007/s10227-005-0136-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
160 Korta DZ, Christiano AM, Bergfeld W, Duvic M, Ellison A, Fu J, Harris JE, Hordinsky MK, King B, Kranz D, Mackay-Wiggan J, McMichael A, Norris DA, Price V, Shapiro J, Atanaskova Mesinkovska N. Alopecia areata is a medical disease. J Am Acad Dermatol 2018;78:832-4. [PMID: 29548423 DOI: 10.1016/j.jaad.2017.09.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
161 Wessman LL, Andersen LK, Davis MDP. Incidence of diseases primarily affecting the skin by age group: population-based epidemiologic study in Olmsted County, Minnesota, and comparison with age-specific incidence rates worldwide. Int J Dermatol 2018;57:1021-34. [PMID: 29377079 DOI: 10.1111/ijd.13904] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
162 Papadopoulos AJ, Schwartz RA, Janniger CK. Alopecia areata. Pathogenesis, diagnosis, and therapy. Am J Clin Dermatol 2000;1:101-5. [PMID: 11702308 DOI: 10.2165/00128071-200001020-00004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
163 Ahmed AM, Barahmani N, Duvic M. Familial alopecia areata and chronic thrombocytopenia. Journal of the American Academy of Dermatology 2008;58:S75-7. [DOI: 10.1016/j.jaad.2007.05.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
164 Lavian J, Li SJ, Lee EY, Bordone LA, Polubriaginof FCG, Christiano AM, Mostaghimi A. Validation of Case Identification for Alopecia Areata Using International Classification of Diseases Coding. Int J Trichology 2020;12:234-7. [PMID: 33531746 DOI: 10.4103/ijt.ijt_67_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
165 Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62:177-188, quiz 189-190. [PMID: 20115945 DOI: 10.1016/j.jaad.2009.10.032] [Cited by in Crossref: 235] [Cited by in F6Publishing: 140] [Article Influence: 21.4] [Reference Citation Analysis]
166 Trüeb RM, Dutra H, Dias MFRG. A Comment on JAK Inhibitors for Treatment of Alopecia Areata. Int J Trichology 2018;10:193-7. [PMID: 30607037 DOI: 10.4103/ijt.ijt_62_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
167 Han Y, Sheng Y, Xu F, Qi S, Liu X, Hu R, Miao Y, Huang G, Yang Q. Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata. J Dermatol 2015;42:981-8. [DOI: 10.1111/1346-8138.12978] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
168 Wikramanayake TC, Alvarez-Connelly E, Simon J, Mauro LM, Guzman J, Elgart G, Schachner LA, Chen J, Plano LR, Jimenez JJ. Heat treatment increases the incidence of alopecia areata in the C3H/HeJ mouse model. Cell Stress Chaperones 2010;15:985-91. [PMID: 20582641 DOI: 10.1007/s12192-010-0209-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
169 Dai Z, Xing L, Cerise J, Wang EH, Jabbari A, de Jong A, Petukhova L, Christiano AM, Clynes R. CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata. J Immunol 2016;197:1089-99. [PMID: 27412416 DOI: 10.4049/jimmunol.1501798] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 7.6] [Reference Citation Analysis]
170 Strober BE, Siu K, Alexis AF, Kim G, Washenik K, Sinha A, Shupack JL. Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study. J Am Acad Dermatol 2005;52:1082-4. [PMID: 15928633 DOI: 10.1016/j.jaad.2005.03.039] [Cited by in Crossref: 69] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
171 Weedon D. Diseases of cutaneous appendages. Weedon's Skin Pathology. Elsevier; 2010. pp. 397-440.e34. [DOI: 10.1016/b978-0-7020-3485-5.00016-4] [Cited by in Crossref: 10] [Article Influence: 0.9] [Reference Citation Analysis]
172 Tiwary AK, Mishra DK, Chaudhary SS. Comparative Study of Efficacy and Safety of Topical Squaric Acid Dibutylester and Diphenylcyclopropenone for the Treatment of Alopecia Areata. N Am J Med Sci 2016;8:237-42. [PMID: 27500127 DOI: 10.4103/1947-2714.185029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
173 Tang L, Sundberg JP, Lui H, Shapiro J. Old wine in new bottles: reviving old therapies for alopecia areata using rodent models. J Investig Dermatol Symp Proc 2003;8:212-6. [PMID: 14582676 DOI: 10.1046/j.1087-0024.2003.00812.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
174 Nakajima T, Inui S, Itami S. Pulse corticosteroid therapy for alopecia areata: study of 139 patients. Dermatology. 2007;215:320-324. [PMID: 17911990 DOI: 10.1159/000107626] [Cited by in Crossref: 53] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
175 You HR, Kim SJ. Factors Associated with Severity of Alopecia Areata. Ann Dermatol 2017;29:565-70. [PMID: 28966512 DOI: 10.5021/ad.2017.29.5.565] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
176 Glickman JW, Dubin C, Renert-Yuval Y, Dahabreh D, Kimmel GW, Auyeung K, Estrada YD, Singer G, Krueger JG, Pavel AB, Guttman-Yassky E. Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation. J Am Acad Dermatol 2021;84:370-80. [PMID: 32376430 DOI: 10.1016/j.jaad.2020.04.138] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
177 Jenneck C, Foelster-Holst R, Hagemann T, Novak N. [Associated diseases and differential diagnostic considerations in childhood atopic eczema]. Hautarzt 2007;58:163-74; quiz 175-6. [PMID: 17268788 DOI: 10.1007/s00105-006-1279-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
178 Nilforoushzadeh MA, Keshtmand G, Jaffary F, Kheirkhah A. Diphencyprone induced vitiligo: a case report. Case Rep Med 2012;2012:356236. [PMID: 22811720 DOI: 10.1155/2012/356236] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
179 Hill ND, Bunata K, Hebert AA. Treatment of alopecia areata with squaric acid dibutylester. Clin Dermatol 2015;33:300-4. [PMID: 25889130 DOI: 10.1016/j.clindermatol.2014.12.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
180 Lee S, Lee W. Management of alopecia areata: Updates and algorithmic approach. J Dermatol 2017;44:1199-211. [DOI: 10.1111/1346-8138.13933] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
181 Lai VWY, Chen G, Gin D, Sinclair R. Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety. Journal of the American Academy of Dermatology 2019;81:694-701. [DOI: 10.1016/j.jaad.2019.04.053] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 11.5] [Reference Citation Analysis]
182 Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007;29:1-9. [PMID: 17582741 DOI: 10.1016/j.jaut.2007.05.002] [Cited by in Crossref: 239] [Cited by in F6Publishing: 204] [Article Influence: 17.1] [Reference Citation Analysis]
183 Chow S, Rizzo C, Ravitskiy L, Sinha AA. The role of T cells in cutaneous autoimmune disease. Autoimmunity 2009;38:303-17. [DOI: 10.1080/08916930500124429] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
184 Simakou T, Butcher JP, Reid S, Henriquez FL. Alopecia areata: A multifactorial autoimmune condition. J Autoimmun. 2019;98:74-85. [PMID: 30558963 DOI: 10.1016/j.jaut.2018.12.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 9.3] [Reference Citation Analysis]
185 Lee S, Lee YB, Kim BJ, Lee W. Screening of thyroid function and autoantibodies in patients with alopecia areata: A systematic review and meta-analysis. Journal of the American Academy of Dermatology 2019;80:1410-1413.e4. [DOI: 10.1016/j.jaad.2018.10.066] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
186 Wang E, Lee JS, Tang M. Current treatment strategies in pediatric alopecia areata. Indian J Dermatol 2012;57:459-65. [PMID: 23248364 DOI: 10.4103/0019-5154.103066] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
187 Freyschmidt-paul P, Happle R, Metz S, Hoffmann R, Sundberg JP, Mcelwee KJ, Boggess D. Successful Treatment of Alopecia Areata-Like Hair Loss with the Contact Sensitizer Squaric Acid Dibutylester (SADBE) in C3H/HeJ Mice. Journal of Investigative Dermatology 1999;113:61-8. [DOI: 10.1046/j.1523-1747.1999.00640.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 2.3] [Reference Citation Analysis]
188 Mackay-Wiggan J, Jabbari A, Nguyen N, Cerise JE, Clark C, Ulerio G, Furniss M, Vaughan R, Christiano AM, Clynes R. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata. JCI Insight 2016;1:e89790. [PMID: 27699253 DOI: 10.1172/jci.insight.89790] [Cited by in Crossref: 132] [Cited by in F6Publishing: 105] [Article Influence: 26.4] [Reference Citation Analysis]
189 Tazi-ahnini R, Cork M, Gawkrodger D, Birch M, Wengraf D, Mcdonagh A, Messenger A. Role of the Autoimmune Regulator ( AIRE ) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis: Tazi-Ahnini et al : AIRE gene in alopecia areata. Tissue Antigens 2002;60:489-95. [DOI: 10.1034/j.1399-0039.2002.600604.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
190 Im M, Lee SS, Lee Y, Kim CD, Seo YJ, Lee JH, Park JK. Prognostic factors in methylprednisolone pulse therapy for alopecia areata. J Dermatol 2011;38:767-72. [PMID: 21592197 DOI: 10.1111/j.1346-8138.2010.01135.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
191 Le Bidre E, Chaby G, Martin L, Perrussel M, Sassolas B, Sigal ML, Kaassis C, Lespessailles E, Nseir A, Estève E. [Alopecia areata during anti-TNF alpha therapy: Nine cases]. Ann Dermatol Venereol 2011;138:285-93. [PMID: 21497255 DOI: 10.1016/j.annder.2011.01.047] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
192 Tazi-ahnini R, Mcdonagh AJG, Cox A, Messenger AG, Britton JER, Ward SJ, Båvik CO, Duff GW, Cork MJ. Association analysis of IL1A and IL1B variants in alopecia areata. Heredity 2001;87:215-9. [DOI: 10.1046/j.1365-2540.2001.00916.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
193 Azzawi S, Penzi LR, Senna MM. Immune Privilege Collapse and Alopecia Development: Is Stress a Factor. Skin Appendage Disord 2018;4:236-44. [PMID: 30410890 DOI: 10.1159/000485080] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
194 Tobin D, Gardner S, Luther P, Dunston S, Lindsey N, Olivry T. A natural canine homologue of alopecia areata in humans. Br J Dermatol 2003;149:938-50. [DOI: 10.1111/j.1365-2133.2003.05610.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
195 Chiang KS, Mesinkovska NA, Piliang MP, Bergfeld WF. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients. J Investig Dermatol Symp Proc 2015;17:50-5. [PMID: 26551948 DOI: 10.1038/jidsymp.2015.28] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
196 Uchiyama M, Egusa C, Hobo A, Irisawa R, Yamazaki M, Tsuboi R. Multivariate analysis of prognostic factors in patients with rapidly progressive alopecia areata. Journal of the American Academy of Dermatology 2012;67:1163-73. [DOI: 10.1016/j.jaad.2012.06.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
197 Gilhar A, Kalish RS. Alopecia Areata: A tissue specific autoimmune disease of the hair follicle. Autoimmunity Reviews 2006;5:64-9. [DOI: 10.1016/j.autrev.2005.07.001] [Cited by in Crossref: 126] [Cited by in F6Publishing: 98] [Article Influence: 8.4] [Reference Citation Analysis]
198 Wikramanayake TC, Villasante AC, Mauro LM, Perez CI, Schachner LA, Jimenez JJ. Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model. Cell Stress Chaperones 2012;17:267-74. [PMID: 22042611 DOI: 10.1007/s12192-011-0305-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
199 De Vere Hunt IJ, Howard E, McPherson T. The impact of chronic skin disease in adolescence and the need for specialist adolescent services. Clin Exp Dermatol 2020;45:5-9. [PMID: 31236992 DOI: 10.1111/ced.14021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
200 Açıkgöz G, Yeşil H, Çalışkan E, Tunca M, Akar A. Targeted photochemotherapy in alopecia areata: Targeted photochemotherapy in AA. Photodermatol Photoimmunol Photomed 2013;29:318-22. [DOI: 10.1111/phpp.12073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
201 Tafazzoli A, Forstner AJ, Broadley D, Hofmann A, Redler S, Petukhova L, Giehl KA, Kruse R, Blaumeiser B, Böhm M, Bertolini M, Rossi A, Garcia Bartels N, Lutz G, Wolff H, Blume-Peytavi U, Soreq H, Christiano AM, Botchkareva NV, Nöthen MM, Betz RC. Genome-Wide MicroRNA Analysis Implicates miR-30b/d in the Etiology of Alopecia Areata. J Invest Dermatol 2018;138:549-56. [PMID: 29080678 DOI: 10.1016/j.jid.2017.09.046] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
202 King B, Guttman-Yassky E, Peeva E, Banerjee A, Sinclair R, Pavel AB, Zhu L, Cox LA, Craiglow B, Chen L, Banfield C, Page K, Zhang W, Vincent MS. A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results. J Am Acad Dermatol 2021;85:379-87. [PMID: 33757798 DOI: 10.1016/j.jaad.2021.03.050] [Reference Citation Analysis]
203 Agirbasli M, Eren M, Yasar S, Delil K, Goktay F, Oner ET, Vaughan DE. Functionally stable plasminogen activator inhibitor-1 in a family with cardiovascular disease and vitiligo. J Thromb Thrombolysis 2014;38:50-6. [PMID: 24197654 DOI: 10.1007/s11239-013-1021-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
204 Neuhausen SL, Steele L, Ryan S, Mousavi M, Pinto M, Osann KE, Flodman P, Zone JJ. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J Autoimmun 2008;31:160-5. [PMID: 18692362 DOI: 10.1016/j.jaut.2008.06.001] [Cited by in Crossref: 74] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
205 Gilhar A, Keren A, Shemer A, d'Ovidio R, Ullmann Y, Paus R. Autoimmune disease induction in a healthy human organ: a humanized mouse model of alopecia areata. J Invest Dermatol 2013;133:844-7. [PMID: 23096715 DOI: 10.1038/jid.2012.365] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
206 Lew BL, Shin MK, Sim WY. Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis. J Am Acad Dermatol 2009;60:85-93. [PMID: 18992964 DOI: 10.1016/j.jaad.2008.08.045] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
207 Fichna M, Fichna P, Gryczyńska M, Walkowiak J, Żurawek M, Sowiński J. Screening for associated autoimmune disorders in Polish patients with Addison’s disease. Endocr 2010;37:349-60. [DOI: 10.1007/s12020-010-9312-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
208 Jackow C, Puffer N, Hordinsky M, Nelson J, Tarrand J, Duvic M. Alopecia areata and cytomegalovirus infection in twins: genes versus environment? J Am Acad Dermatol 1998;38:418-25. [PMID: 9520023 DOI: 10.1016/s0190-9622(98)70499-2] [Cited by in Crossref: 91] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
209 Burroway B, Griggs J, Tosti A. Alopecia totalis and universalis long‐term outcomes: a review. J Eur Acad Dermatol Venereol 2020;34:709-15. [DOI: 10.1111/jdv.15994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
210 Aldhouse NVJ, Kitchen H, Knight S, Macey J, Nunes FP, Dutronc Y, Mesinkovska N, Ko JM, King BA, Wyrwich KW. "'You lose your hair, what's the big deal?' I was so embarrassed, I was so self-conscious, I was so depressed:" a qualitative interview study to understand the psychosocial burden of alopecia areata. J Patient Rep Outcomes 2020;4:76. [PMID: 32914253 DOI: 10.1186/s41687-020-00240-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
211 Guzmán-Sánchez DA, Villanueva-Quintero GD, Alfaro Alfaro N, McMichael A. A clinical study of alopecia areata in Mexico. Int J Dermatol 2007;46:1308-10. [PMID: 18173532 DOI: 10.1111/j.1365-4632.2007.03320.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
212 Sohn K, Jang S, Choi D, Lee Y, Yoon T, Jeon EK, Kim KH, Seo Y, Lee J, Park J, Kim CD. Effect of thioredoxin reductase 1 on glucocorticoid receptor activity in human outer root sheath cells. Biochemical and Biophysical Research Communications 2007;356:810-5. [DOI: 10.1016/j.bbrc.2007.03.065] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
213 Tobin DJ. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J Investig Dermatol Symp Proc 2003;8:176-81. [PMID: 14582669 DOI: 10.1046/j.1087-0024.2003.00805.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
214 Li Y, Kilani RT, Pakyari M, Leung G, Nabai L, Ghahary A. Increased expression of PD-L1 and PD-L2 in dermal fibroblasts from alopecia areata mice. J Cell Physiol 2018;233:2590-601. [PMID: 28777458 DOI: 10.1002/jcp.26134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
215 Xiao FL, Yang S, Liu JB, He PP, Yang J, Cui Y, Yan KL, Gao M, Liang YH, Zhang XJ. The epidemiology of childhood alopecia areata in China: a study of 226 patients. Pediatr Dermatol 2006;23:13-8. [PMID: 16445403 DOI: 10.1111/j.1525-1470.2006.00161.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
216 Chu SY, Chen YJ, Tseng WC, Lin MW, Chen TJ, Hwang CY, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol 2011;65:949-56. [PMID: 21616562 DOI: 10.1016/j.jaad.2010.08.032] [Cited by in Crossref: 117] [Cited by in F6Publishing: 91] [Article Influence: 11.7] [Reference Citation Analysis]
217 Nikkels AF, Nikkels-Tassoudji N, Piérard GE. Cutaneous adverse reactions following anti-infective vaccinations. Am J Clin Dermatol 2005;6:79-87. [PMID: 15799679 DOI: 10.2165/00128071-200506020-00002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
218 Patel D, Li P, Bauer AJ, Castelo-Soccio L. Screening Guidelines for Thyroid Function in Children With Alopecia Areata. JAMA Dermatol 2017;153:1307-10. [PMID: 28973128 DOI: 10.1001/jamadermatol.2017.3694] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
219 Bozic Antic I, Macut D, Popovic B, Isailovic T, Petakov M, Ognjanovic S, Damjanovic S. Recurrent spontaneous abortions, Hashimoto thyroiditis and alopecia totalis: response to anticoagulation and intravenous immunoglobulin therapy. Gynecol Endocrinol 2014;30:100-2. [PMID: 24308767 DOI: 10.3109/09513590.2013.864271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
220 Betz RC, Petukhova L, Ripke S, Huang H, Menelaou A, Redler S, Becker T, Heilmann S, Yamany T, Duvic M, Hordinsky M, Norris D, Price VH, Mackay-Wiggan J, de Jong A, DeStefano GM, Moebus S, Böhm M, Blume-Peytavi U, Wolff H, Lutz G, Kruse R, Bian L, Amos CI, Lee A, Gregersen PK, Blaumeiser B, Altshuler D, Clynes R, de Bakker PIW, Nöthen MM, Daly MJ, Christiano AM. Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun 2015;6:5966. [PMID: 25608926 DOI: 10.1038/ncomms6966] [Cited by in Crossref: 116] [Cited by in F6Publishing: 87] [Article Influence: 19.3] [Reference Citation Analysis]
221 Bernardis E, Castelo-soccio L. Quantifying Alopecia Areata via Texture Analysis to Automate the SALT Score Computation. Journal of Investigative Dermatology Symposium Proceedings 2018;19:S34-40. [DOI: 10.1016/j.jisp.2017.10.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
222 Villasante Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol 2015;8:397-403. [PMID: 26244028 DOI: 10.2147/CCID.S53985] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
223 Betz RC, König K, Flaquer A, Redler S, Eigelshoven S, Kortüm AK, Hanneken S, Hillmer A, Tüting T, Lambert J, De Weert J, Kruse R, Lutz G, Blaumeiser B, Nöthen MM. The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata. Br J Dermatol 2008;158:389-91. [PMID: 18028494 DOI: 10.1111/j.1365-2133.2007.08312.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
224 Kavak A, Yeşildal N, Parlak AH, Gökdemir G, Aydoğan I, Anul H, Baykal C. Alopecia areata in Turkey: demographic and clinical features. J Eur Acad Dermatol Venereol 2008;22:977-81. [PMID: 18384559 DOI: 10.1111/j.1468-3083.2008.02699.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
225 Picardi A, Pasquini P, Cattaruzza MS, Gaetano P, Baliva G, Melchi CF, Papi M, Camaioni D, Tiago A, Gobello T, Biondi M. Psychosomatic factors in first-onset alopecia areata. Psychosomatics. 2003;44:374-381. [PMID: 12954911 DOI: 10.1176/appi.psy.44.5.374] [Cited by in Crossref: 63] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
226 Kalia S, Lui H. Utilizing Electromagnetic Radiation for Hair Growth. Dermatologic Clinics 2013;31:193-200. [DOI: 10.1016/j.det.2012.08.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
227 Lalosevic J, Gajic-veljic M, Bonaci-nikolic B, Nikolic M. Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long-term follow-up study: Combined pulse and topical corticosteroid therapy. Dermatologic Therapy 2015;28:309-17. [DOI: 10.1111/dth.12255] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
228 Sehgal VN, Jain S. Alopecia Areata: Clinical Perspective and an Insight into Pathogenesis. The Journal of Dermatology 2003;30:271-89. [DOI: 10.1111/j.1346-8138.2003.tb00389.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
229 Duvic M, Nelson A, de Andrade M. The genetics of alopecia areata. Clinics in Dermatology 2001;19:135-9. [DOI: 10.1016/s0738-081x(00)00124-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Conteduca G, Rossi A, Megiorni F, Parodi A, Ferrera F, Tardito S, Battaglia F, Kalli F, Negrini S, Pizzuti A, Rizza E, Indiveri F, Fenoglio D, Filaci G. Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia Areata. Clin Exp Med 2014;14:91-7. [DOI: 10.1007/s10238-012-0224-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
231 Pforr J, Blaumeiser B, Becker T, Freudenberg-hua Y, Hanneken S, Eigelshoven S, Cuyt I, De Weert J, Lambert J, Kruse R, Nothen MM, Betz RC. Investigation of the p.Ser278Arg polymorphism of the autoimmune regulator (AIRE) gene in alopecia areata. Tissue Antigens 2006;68:58-61. [DOI: 10.1111/j.1399-0039.2006.00598.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
232 Bilgic O, Sivrikaya A, Unlu A, Altinyazar HC. Serum cytokine and chemokine profiles in patients with alopecia areata. Journal of Dermatological Treatment 2015;27:260-3. [DOI: 10.3109/09546634.2015.1093591] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
233 Bortnichak EA, Wise RP, Salive ME, Tilson HH. Proactive safety surveillance. Pharmacoepidem Drug Safe 2001;10:191-6. [DOI: 10.1002/pds.587] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
234 Petukhova L, Cabral RM, Mackay-wiggan J, Clynes R, Christiano AM. The genetics of alopecia areata: What's new and how will it help our patients?: GWAS initiates translational work in AA. Dermatologic Therapy 2011;24:326-36. [DOI: 10.1111/j.1529-8019.2011.01411.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
235 Renert-Yuval Y, Guttman-Yassky E. The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm. Adv Ther 2017;34:1594-609. [PMID: 28646393 DOI: 10.1007/s12325-017-0542-7] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
236 Carroll JM, Byrne MC, Mcelwee KJ, King LE, Sundberg JP. Gene Array Profiling and Immunomodulation Studies Define a Cell-Mediated Immune Response Underlying the Pathogenesis of Alopecia Areata in a Mouse Model and Humans. Journal of Investigative Dermatology 2002;119:392-402. [DOI: 10.1046/j.1523-1747.2002.01811.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 71] [Article Influence: 4.3] [Reference Citation Analysis]
237 Guttman-yassky E, Nia JK, Hashim PW, Mansouri Y, Alia E, Taliercio M, Desai PN, Lebwohl MG. Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata. Arch Dermatol Res 2018;310:607-14. [DOI: 10.1007/s00403-018-1853-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
238 McElwee KJ, Gilhar A, Tobin DJ, Ramot Y, Sundberg JP, Nakamura M, Bertolini M, Inui S, Tokura Y, King LE Jr, Duque-Estrada B, Tosti A, Keren A, Itami S, Shoenfeld Y, Zlotogorski A, Paus R. What causes alopecia areata? Exp Dermatol 2013;22:609-26. [PMID: 23947678 DOI: 10.1111/exd.12209] [Cited by in Crossref: 88] [Cited by in F6Publishing: 68] [Article Influence: 12.6] [Reference Citation Analysis]
239 Amin SS, Sachdeva S. Alopecia areata: A review. Journal of the Saudi Society of Dermatology & Dermatologic Surgery 2013;17:37-45. [DOI: 10.1016/j.jssdds.2013.05.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
240 Wengraf DA, Mcdonagh AJG, Lovewell TRJ, Vasilopoulos Y, Macdonald-hull SP, Cork MJ, Messenger AG, Tazi-ahnini R. Genetic analysis of autoimmune regulator haplotypes in alopecia areata. Tissue Antigens 2008;71:206-12. [DOI: 10.1111/j.1399-0039.2007.00992.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
241 Redler S, Albert F, Brockschmidt F, Herold C, Hanneken S, Eigelshoven S, Giehl K, Kruse R, Lutz G, Wolff H, Blaumeiser B, Böhm M, Becker T, Nöthen M, Betz R. Investigation of selected cytokine genes suggests that IL2RA and the TNF / LTA locus are risk factors for severe alopecia areata. British Journal of Dermatology 2012;167:1360-5. [DOI: 10.1111/bjd.12004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
242 Mokhtari F, Panjehpour T, Naeini FF, Hosseini SM, Nilforoushzadeh MA, Matin M. The Frequency Distribution of Celiac Autoantibodies in Alopecia Areata. Int J Prev Med 2016;7:109. [PMID: 27833723 DOI: 10.4103/2008-7802.190607] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
243 Domashenko A, Gupta S, Cotsarelis G. Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex. Nat Biotechnol 2000;18:420-3. [DOI: 10.1038/74480] [Cited by in Crossref: 91] [Cited by in F6Publishing: 71] [Article Influence: 4.3] [Reference Citation Analysis]
244 Turner CT, Lim D, Granville DJ. Granzyme B in skin inflammation and disease. Matrix Biology 2019;75-76:126-40. [DOI: 10.1016/j.matbio.2017.12.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 16.0] [Reference Citation Analysis]
245 Mcdonagh AJG, Tazi-ahnini R. Epidemiology and genetics of alopecia areata: Epidemiology and genetics of alopecia areata. Clinical and Experimental Dermatology 2002;27:405-9. [DOI: 10.1046/j.1365-2230.2002.01077.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 92] [Article Influence: 6.0] [Reference Citation Analysis]
246 Betz RC, Pforr J, Flaquer A, Redler S, Hanneken S, Eigelshoven S, Kortüm A, Tüting T, Lambert J, De Weert J, Hillmer AM, Schmael C, Wienker TF, Kruse R, Lutz G, Blaumeiser B, Nöthen MM. Loss-of-Function Mutations in the Filaggrin Gene and Alopecia Areata: Strong Risk Factor for a Severe Course of Disease in Patients Comorbid for Atopic Disease. Journal of Investigative Dermatology 2007;127:2539-43. [DOI: 10.1038/sj.jid.5700915] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]